Gudmund Tyge Korsgaard
Vorstandsvorsitzender bei Tyge Korsgaard Consult ApS
Profil
Gudmund Tyge Korsgaard is currently the Chief Executive Officer & Director at Den Sociale Kapitalfond Invest I K and the Chief Executive Officer at Tyge Korsgaard Consult ApS.
He is also the Chairman at Vivostat A and Vivostat Holding ApS, and a Director at Familien Skak Holding ApS, Gribskov Gruppen AS, Caissa Group ApS, and Fonden DSK Invest I GP.
In the past, he served as the Chairman at NsGene A, Director at CAPRES A, TD Vaccines A, and Pila Pharma AB, and Senior Investment Manager at MAJ Invest Equity A.
He was also an Investment Manager at Fondsmæglerselskabet Maj Invest A.
Korsgaard graduated from the University of Aalborg.
Aktive Positionen von Gudmund Tyge Korsgaard
Unternehmen | Position | Beginn |
---|---|---|
Vivostat A/S
Vivostat A/S Medical SpecialtiesHealth Technology Vivostat A/S provides cardiac, thoracic and orthopaedic surgery medical devices. It offers vivostat system, an automated system for the on-site preparation and application of patient-derived fibrin sealant or platelet rich fibrin. Its products include Vivostat autologous fibrin sealant for various settings in surgical areas, transfusion centers, or blood banks and Vivostat platelet rich fibrin, which utilizes the patient's own blood to derive either a surgical sealant to prevent and stop bleedings, or a gel with a high concentration of growth factors that stimulates the healing of chronic wounds, as well as provides application devices. The compnay was founded in 2001 by Tom Bjerg Lauritzen and Niels Hvid and is headquartered in Alleroed, Denmark. | Vorsitzender | 01.01.2000 |
Vivostat Holding ApS | Vorsitzender | - |
Den Sociale Kapitalfond Invest I K/S
Den Sociale Kapitalfond Invest I K/S Investment ManagersFinance Den Sociale Kapitalfond Invest I K/S is a social impact fund investing in small and mid-size companies located in Denmark and Sweden. The fund targets companies operating in industries such as manufacturing, consumer durables and services, and with annual revenues of DKK 30 to 200 million. It provides financing for growth-stage capital requirements, and makes co-investments. The fund looks to take minority stake positions, and a seat on the board. | Vorstandsvorsitzender | - |
Familien Skak Holding ApS | Direktor/Vorstandsmitglied | - |
Gribskov Gruppen AS | Direktor/Vorstandsmitglied | - |
Caissa Group ApS
Caissa Group ApS Miscellaneous Commercial ServicesCommercial Services Caissa Group ApS provides services in research design programs. | Direktor/Vorstandsmitglied | - |
Tyge Korsgaard Consult ApS | Vorstandsvorsitzender | - |
Fonden DSK Invest I GP | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Gudmund Tyge Korsgaard
Unternehmen | Position | Ende |
---|---|---|
PILA PHARMA AB | Direktor/Vorstandsmitglied | 07.06.2022 |
░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░ ░░░░░░ ░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░ | ░░░░░░░░░░░░ | - |
░░░░░░░░░░░░░░░░░░░░░ ░░░ ░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Gudmund Tyge Korsgaard
University of Aalborg | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
PILA PHARMA AB | Health Technology |
Private Unternehmen | 13 |
---|---|
MAJ Invest Equity A/S
MAJ Invest Equity A/S Investment ManagersFinance MAJ Invest Equity A/S (MAJ Invest) is a private equity subsidiary of Fondsmæglerselskabet MAJ Invest A/S, itself a subsidiary of MAJ Invest Holding A/S. The firm was founded in 2005 and is headquartered in Copenhagen, Denmark. | Finance |
Vivostat A/S
Vivostat A/S Medical SpecialtiesHealth Technology Vivostat A/S provides cardiac, thoracic and orthopaedic surgery medical devices. It offers vivostat system, an automated system for the on-site preparation and application of patient-derived fibrin sealant or platelet rich fibrin. Its products include Vivostat autologous fibrin sealant for various settings in surgical areas, transfusion centers, or blood banks and Vivostat platelet rich fibrin, which utilizes the patient's own blood to derive either a surgical sealant to prevent and stop bleedings, or a gel with a high concentration of growth factors that stimulates the healing of chronic wounds, as well as provides application devices. The compnay was founded in 2001 by Tom Bjerg Lauritzen and Niels Hvid and is headquartered in Alleroed, Denmark. | Health Technology |
CAPRES A/S
CAPRES A/S Electronic Production EquipmentElectronic Technology CAPRES A/S develops, manufactures, and sells micro-scale electromechanical components and systems. It specializes in technology that allows direct measurement of sheet resistance, Hall Mobility, and Active Carrier Density. The company was founded by Peter Folmer Nielsen, Christian Leth Petersen, and Ulrik Quade in 1999 and is headquartered in Kongens Lyngby, Denmark. | Electronic Technology |
TD Vaccines A/S
TD Vaccines A/S Pharmaceuticals: MajorHealth Technology TD Vaccines A/S S is a holding company that focuses on the development of vaccines to protect against travellers' diarrhoea (TD). It is a biotechnology company that discovers and develops novel vaccines to fight serious bacterial infections. Its lead programme is ACE527, an oral ETEC vaccine to protect against ETEC (Enterotoxigenic E Coli). Its oral combination vaccine, ACE920, designs to protect against ETEC and Campylobacter infections. The company was founded in November 2009 and is headquartered in Skorping, Denmark. | Health Technology |
Fondsmæglerselskabet Maj Invest A/S
Fondsmæglerselskabet Maj Invest A/S Investment ManagersFinance Fondsmæglerselskabet Maj Invest A/S (FM Invest) is the wholly-owned asset management subsidiary of Maj Invest Holding A/S in Denmark. The firm was founded in 2005 and is headquartered in Copenhagen. FM Invest provides advice on strategic asset allocation and asset management of securities listed on regulated markets for institutional clients and serves as the investment adviser to the Maj Invest mutual funds in Denmark and Luxembourg, which are owned by their members. They also offer wealth management services to wealthy individuals, companies and funds. | Finance |
NsGene A/S
NsGene A/S Pharmaceuticals: MajorHealth Technology NsGene A/S identifies neurotrophic proteins with therapeutic effects in the nervous system. It is a biotechnology company that focuses primarily on neurodegenerative disorders. The firm provides technologies that target protein therapeutics across the blood-brain-barrier and directly to diseased nerve cells. It develops therapeutic products for multiple indications with high medical needs including Alzheimer’s disease, Parkinson's disease, deafness, neuropathic pain, epilepsy, cortico-basal degeneration, and Huntington’s disease. The company was founded by Lars Ulrik Wahlberg and Teit Eliot Johansen in 1999 and is headquartered in Ballerup, Denmark. | Health Technology |
Vivostat Holding ApS | |
Den Sociale Kapitalfond Invest I K/S
Den Sociale Kapitalfond Invest I K/S Investment ManagersFinance Den Sociale Kapitalfond Invest I K/S is a social impact fund investing in small and mid-size companies located in Denmark and Sweden. The fund targets companies operating in industries such as manufacturing, consumer durables and services, and with annual revenues of DKK 30 to 200 million. It provides financing for growth-stage capital requirements, and makes co-investments. The fund looks to take minority stake positions, and a seat on the board. | Finance |
Familien Skak Holding ApS | |
Gribskov Gruppen AS | |
Caissa Group ApS
Caissa Group ApS Miscellaneous Commercial ServicesCommercial Services Caissa Group ApS provides services in research design programs. | Commercial Services |
Tyge Korsgaard Consult ApS | |
Fonden DSK Invest I GP |